Zydus extends closing date for Sterling Biotech API acquisition

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹917.00

prior close

₹917.85

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.3%-0.3% vs market

Pharmaceuticals peers, median of 153sector-0.5%-0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty 100 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

+0.1

15m

-0.1

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-0.3-0.3-0.5-0.1

Next day

-1.5-0.7-0.8-1.3-0.2

-1.6-0.7-0.9-1.3-0.2

-0.3+0.1-0.4-0.6+0.2

-0.1+0.2-0.3-0.7+0.6

+0.1+0.9-0.8+0.4-0.3

+1.6+0.5+1.1+0.2+1.4

15d

-4.2-1.8-2.3-4.0-0.2

-2.7-3.6+0.9-7.9+5.1

+2.3-1.7+4.0-6.2+8.6

-2.3-12.3+10.0-15.2+12.9

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences is acquiring the API business of Sterling Biotech under a Business Transfer Agreement signed in September 2024. SBL is still completing conditions precedent, so both parties have extended the closing date to June 30, 2026, from the previously revised deadline of December 31, 2025. Deal value was not disclosed in this update.

Likely market impact

Further delay in a non-core API acquisition from Sterling Biotech; closing pushed to June 2026. Minimal immediate impact on Zydus main business.